Compound information
- Natural Products
- ZC1928828
- Molecular Formula
- C19H21N3O3
- Molecular Weight
- 339.158291532 g/mol
- Structure
-
- IUPAC Name
- benzyl (2R)-2-(3-pyridylcarbamoyl)piperidine-1-carboxylate
- InChI
- InChI=1S/C19H21N3O3/c23-18(21-16-9-6-11-20-13-16)17-10-4-5-12-22(17)19(24)25-14-15-7-2-1-3-8-15/h1-3,6-9,11,13,17H,4-5,10,12,14H2,(H,21,23)/t17-/m1/s1
- InChI Key
- GUQGBWVSEAWYQA-QGZVFWFLSA-N
- SMILES
- O=C(Nc1cccnc1)[C@H]1CCCCN1C(=O)OCc1ccccc1
- Source
- ZINC000040107213
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 71.53 Å2 | LogP | 3.102 |
LogS | -3.01 | LogD | 2.898 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.715 | Pgp substrate | 0.027 |
HIA | 0.964 | F20 % | 0.926 |
F30 % | 0.212 | Caco-2 | -4.536 |
MDCK | -4.707 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.306 | PPB | 56.341 |
VD | 1.022 | Fu | 0.805 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.749 | CYP1A2 substrate | 0.68 |
CYP2A6 substrate | 0.775 | CYP2B6 substrate | 0.699 |
CYP2C19 inhibitor | 0.963 | CYP2C19 substrate | 0.786 |
CYP2C8 substrate | 0.707 | CYP2C9 inhibitor | 0.976 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.474 |
CYP2D6 substrate | 0.966 | CYP2E1 substrate | 0.824 |
CYP3A4 inhibitor | 0.663 | CYP3A4 substrate | 0.993 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.744 | CL | 6.903 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.116 | Hepatotoxicity | 0.9 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.235 |
FDAMDD | 0.33 | Skin Sensitization | 0.96 |
Carcinogenicity | 0.02 | Eye Corrosion | 0.002 |
Eye Irritation | 0.005 | Respiratory Toxicity | 0.104 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.207 | IGC50 | 3.32 |
LC50FM | 3.179 | LC50DM | 3.985 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.341 | NR-AR-LBD | 0.183 |
NR-AhR | 0.314 | NR-Aromatase | 0.034 |
NR-ER | 0.271 | NR-ER-LBD | 0.365 |
NR-PPAR-gamma | 0.286 | SR-ARE | 0.623 |
SR-ATAD5 | 0.476 | SR-HSE | 0.187 |
SR-MMP | 0.315 | SR-p53 | 0.052 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.